Results 141 to 150 of about 1,983,235 (163)

Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation. [PDF]

Sci Rep
Kim DH, Shin DY, Koh Y, Kim I, Yoon SS, Byun JM, Hong J.   +6 more
europepmc   +1 more source

Dual <i>in vivo</i> T cell depleted haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and anti-thymocyte globulin as a third salvage transplant for leukocyte adhesion deficiency with graft failure: a case report. [PDF]

Front Immunol
Kiumarsi A, Alaei A, Nikbakht M, Mohammadi S, Ostad-Ali MR, Rasti Z, Rostami T.   +6 more
europepmc   +1 more source

Haploidentical hematopoietic stem cell transplantation for hematologic malignancies: a novel conditioning regimen with anti-T lymphocyte immunoglobulin instead of anti-thymocyte globulin for in vivo T cell depletion. [PDF]

Bone Marrow Transplant
Huang XB, Yang X, Li CL, Zhang R, Wang W, Huang JW, Ye XM, Wang Y, Mao Y, Pu WQ, Zhou Y.   +10 more
europepmc   +1 more source

Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab

Journal of Heart and Lung Transplantation, 2015
The use of induction therapy may reduce the risk of acute rejection after heart transplantation. This study assessed the association between basiliximab (BAS) vs anti-thymocyte globulin (ATG) induction and long-term survival after heart ...
Bodil Andersson, Johan Nilsson, Josef Stehlik   +2 more
exaly   +3 more sources

Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience

Seminars in Hematology, 2016
Haploidentical stem cell transplantation (haplo-SCT) with an anti-thymocyte globulin (ATG) preparative regimen is associated with induced immune tolerance, rapid hematopoietic recovery, effective prevention of graft-versus-host disease (GVHD), and lower ...
XiaoJun Huang, Yingjun Chang
exaly   +2 more sources

Rabbit Anti-Thymocyte Globulin: Evidence for Clinical Benefit in High Immunological Risk Kidney Transplantation

Clinical Medicine Insights Therapeutics, 2011
Rabbit anti-thymocyte globulin is used worldwide to treat and prevent rejection in kidney transplantation. Multiple mechanisms of action of this polyclonal preparation are responsible for its success.
Hani M Wadei, Thomas A Gonwa
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

A case of thymoma showing significant tumor reduction after anti-thymocyte globulin

General Thoracic and Cardiovascular Surgery, 2021
Kensuke Matsuda, Mineo Kurokawa, Toshiya Hino   +2 more
exaly  

Lower Absolute Lymphocyte Count Before Conditioning Predicts High Relapse Risk in Patients After Haploidentical Peripheral Blood Stem Cell Transplantation With Low Dose Anti-Thymocyte Globulin/Post-Transplant Cyclophosphamide for GvHD Prophylaxis

Cell Transplantation, 2022
Liping Wan, Yin Tong, Yu Cai
exaly  

Hematology

Hematology, 2022
Masaki Iino, Atsushi Jinguji
exaly